Abstract
UNLABELLED: To optimize the management of patients with chronic hepatitis C virus (HCV) infection, noninvasive tests to determine the degree of hepatic fibrosis have been developed. The aims of this study were (1) to validate a simple, inexpensive, noninvasive test called FIB-4, which combines standard biochemical values (platelets, ALT, AST) and age, in a series of 847 liver biopsies performed in HCV-monoinfected patients; and (2) to compare the results of 780 FIB-4 and FibroTests performed the same day in a series of 592 HCV-infected patients. The FIB-4 index enabled the correct identification of patients with severe fibrosis (F3-F4) and cirrhosis with an area under the receiver operating characteristic…
Citation impact
- FWCI
- 10.39
- Percentile
- 100%
- References
- 26
Authors
8- AVAnaïs Vallet‐Pichard
Délégation Paris 5, Inserm, Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris
- VMVincent Mallet
Délégation Paris 5, Inserm, Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Paris Cardiovascular Research Center
- BNBertrand Nalpas
Délégation Paris 5, Inserm, Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Paris Cardiovascular Research Center
- VVVirginie Verkarre
Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris
- ANA. Nalpas
Hôpital Cochin, Assistance Publique – Hôpitaux de Paris
Topics & keywords
- Liver biopsy
- Medicine
- Liver fibrosis
- Biopsy
- Hepatitis C
- Internal medicine
- Pathology
- Gastroenterology
- Good health and well-being